Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: Doxycycline in Type II Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update shows doxycycline being studied for Type 2 diabetes in Phase 1 and Phase 2 trials, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

Sponsor: Mostafa Bahaa | Conditions: Diabetes Mellitus, Type 2 | Phase 1, Phase 2 | Status: RECRUITING